Dietary bile acid supplementation improves intestinal integrity and survival in a murine model

Journal of Pediatric Surgery

Volumn 45, Issue 6, 2010, Pages 1256-1265

  Perrone, Erin E ^a,b   Chen, Chen ^a   Longshore, Shannon W ^c,d   Okezie, Oneybuchi ^c   Warner, Brad W ^c   Sun, Chen Chih ^a   Alaish, Samuel M ^a   Strauch, Eric D ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Bile salts; Intestinal injury; Proliferation; Taurodeoxycholic acid (TDCA)

Indexed keywords

BROXURIDINE; CASPASE 3; EOSIN; HEMATOXYLIN; LIPOPOLYSACCHARIDE; TAURODEOXYCHOLIC ACID; CHOLAGOGUE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CRYPT CELL; DIET SUPPLEMENTATION; INTESTINE CELL; INTESTINE CRYPT; INTESTINE INJURY; INTESTINE VILLUS; LIVER INJURY; LUNG INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; STAINING; SURVIVAL TIME; ANIMAL; C57BL MOUSE; DIET THERAPY; DISEASE MODEL; DRUG EFFECTS; INTESTINE MUCOSA; MORTALITY; PATHOLOGY; SHORT BOWEL SYNDROME; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CHOLAGOGUES AND CHOLERETICS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; SHORT BOWEL SYNDROME; SURVIVAL RATE; TAURODEOXYCHOLIC ACID; TREATMENT OUTCOME;

EID: 77953820972     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2010.02.094     Document Type: Article

References (27)

1. Potten C.S., and Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110 (1990) 1001-1020
2. Potten C.S. Epithelial cell growth and differentiation. II. Intestinal apoptosis. Am J Physiol 273 (1997) G253-G257
3. Cheng H., and Leblond C.P. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian theory of the origin of the four epithelial cell types. Am J Anat 141 (1974) 537-561
4. Coopersmith C.M., Stromberg P.E., Davis C.G., et al. Sepsis from Pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest. Crit Care Med 31 (2003) 1630-1637
5. Potoka D.A., Upperman J.S., Zhang X.R., et al. Peroxynitrite inhibits enterocyte proliferation and modulates Src kinase activity in vitro. Am J Physiol Gastrointest Liver Physiol 285 (2003) G861-G869
6. Cinel I., Buyukafsar K., Cinel L., et al. The role of poly(ADP-ribose) synthetase inhibition in preventing endotoxemia-induced intestinal epithelial apoptosis. Pharmacol Res 46 (2002) 119-127
7. Coopersmith C.M., Stromberg P.E., Dunne W.M., et al. Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 287 (2002) 1716-1721
8. Coopersmith C.M., Chang K.C., Swanson P.E., et al. Overexpression of Bcl-2 in the intestinal epithelium improves survival in septic mice. Crit Care Med 30 (2002) 195-201
9. Hofmann A.F. Intestinal absorption of bile acids and biliary constituents. In: Johnson L.R. (Ed). Physiology of the gastrointestinal tract. 3rd ed (1994), Raven Press, New York (NY) 1845-1867
10. Cheng K., and Raufmann J.P. Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors. Biochem Pharmacol 70 (2005) 1035-1047
11. Martinez J.D., Stratagoules E.D., LaRue J.M., et al. Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutr Cancer 31 (1998) 111-118
12. D'Addio V., Sayles J.M., Alvarez C., et al. Bile: a trophic factor for rabbit esophageal epithelium in vitro. Surg Forum 647 (1996) 125-127
13. Toledo A., Yamaguchi J., Wang J.Y., et al. Taurodeoxycholate stimulates intestinal cell proliferation and protects against apoptotic cell death through activation of NF-kappa B. Dig Dis Sci 49 (2004) 1664-1671
14. Strauch E.D., Wang J.Y., and Bass B.L. Bile salt stimulates intestinal epithelial cell migration through TGFbeta after wounding. J Surg Res 97 (2001) 49-53
15. Strauch E.D., Bass B.L., Rao J.N., et al. NF-kappaB regulates intestinal epithelial cell and bile salt-induced migration after injury. Ann Surg 237 (2003) 494-501
16. Sheen-Chen S.M., Chen H.S., Ho H.T., et al. Effect of bile acid replacement on endotoxin-induced tumor necrosis factor-alpha production in obstructive jaundice. World J Surg 26 (2002) 448-450
17. Schneider S.M., Joly F., Gehrardt M.F., et al. Taurine status and response to intravenous taurine supplementation in adults with short-bowel syndrome undergoing long-term parenteral nutrition: a pilot study. Br J Nutr 96 (2006) 365-370
18. Emmett M., Guirl M.J., Santa Ana C.A., et al. Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome. Am J Kidney Dis 41 (2003) 230-237
19. Lorenzo-Zuniga V., Bartoli R., Planas R., et al. Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology 37 (2003) 551-557
20. Clark J.A., Clark A.T., Hotchkiss R.S., et al. Epidermal growth factor treatment decreases mortality and is associated with improved gut integrity in sepsis. Shock 30 (2008) 36-42
21. Carrico C.J., Meakins J.L., Marshall J.C., et al. Multiple-organ-failure syndrome. Arch Surg 121 (1986) 196-208
22. Deitch E.A. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 125 (1990) 403-404
23. Pugin J., and Chevrolet J.C. The intestine-liver-lung axis in septic syndrome. Schweiz Med Wochenschr 121 (1991) 1538-1544
24. Barber A.E., Jones W.G., Minei J.P., et al. Bacterial overgrowth and intestinal atrophy in the etiology of gut barrier failure in the rat. Am J Surg 161 (1991) 300-304
25. Boehm G., Braun W., Moro G., et al. Bile acid concentrations in serum and duodenal aspirates of healthy preterm infants: effects of gestational and postnatal age. Biol Neonate 71 (1997) 207-214
26. Yamato Y., Kimura A., Inoue T., et al. Fetal bile acid metabolism: analysis of urinary 3beta-monohydroxy-delta(5) bile acid in preterm infants. Biol Neonate 80 (2001) 19-25
27. Strandvik B., Wahlen E., and Wikstrom S.A. The urinary bile acid excretion in healthy premature and full-term infants during the neonatal period. Scand J Clin Lab Invest 54 (1994) 1-10